HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sayantani B Sindher Selected Research

Injection Site Reaction

1/2024Omalizumab for the Treatment of Multiple Food Allergies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sayantani B Sindher Research Topics

Disease

15Hypersensitivity (Allergy)
03/2024 - 07/2018
13Food Hypersensitivity (Food Allergy)
03/2024 - 10/2018
10Peanut Hypersensitivity (Peanut Allergy)
03/2024 - 09/2018
4COVID-19
11/2023 - 01/2022
2Eosinophilic Esophagitis
01/2023 - 01/2021
2Anaphylaxis (Anaphylactic Shock)
01/2022 - 01/2021
2Asthma (Bronchial Asthma)
01/2022 - 07/2018
2Atopic Dermatitis (Atopic Eczema)
01/2022 - 01/2020
1Milk Hypersensitivity (Milk Allergy)
02/2024
1Injection Site Reaction
01/2024
1Lung Diseases (Lung Disease)
01/2022
1Infections
01/2022
1Inflammation (Inflammations)
01/2020
1Opportunistic Infections (Opportunistic Infection)
02/2015
1Immune Reconstitution Inflammatory Syndrome
02/2015
1Chronic Urticaria
11/2012

Drug/Important Bio-Agent (IBA)

8AllergensIBA
02/2024 - 01/2020
6Immunoglobulin E (IgE)IBA
02/2024 - 07/2018
4AntigensIBA
11/2023 - 01/2022
4Biomarkers (Surrogate Marker)IBA
11/2023 - 10/2018
4VaccinesIBA
11/2023 - 01/2021
3Omalizumab (Xolair)FDA Link
01/2024 - 07/2018
3mRNA VaccinesIBA
01/2023 - 01/2021
2dupilumabIBA
03/2024 - 01/2023
2AntibodiesIBA
03/2024 - 01/2022
2Proteins (Proteins, Gene)FDA Link
05/2023 - 01/2022
2COVID-19 VaccinesIBA
01/2023 - 01/2021
2EmollientsIBA
10/2022 - 01/2020
2Epinephrine (Adrenaline)FDA LinkGeneric
01/2022 - 01/2020
2Immunoglobulin G (IgG)IBA
01/2022 - 01/2021
2Messenger RNA (mRNA)IBA
01/2022 - 01/2021
1tezepelumabIBA
03/2024
1ligelizumabIBA
03/2024
1anti-IgE antibodiesIBA
01/2024
1AvidinIBA
11/2023
1Excipients (Suspending Agents)IBA
01/2023
1Vaccine ExcipientsIBA
01/2023
1SteroidsIBA
10/2022
1BIBP COVID-19 vaccineIBA
01/2022
1remdesivirIBA
01/2022
1BNT162 VaccineIBA
01/2022
1LeguminsIBA
01/2021
1Histamine Antagonists (Antihistamines)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2018
1Vitamin DFDA LinkGeneric
11/2012

Therapy/Procedure

14Immunotherapy
03/2024 - 09/2018
3Therapeutics
01/2022 - 07/2018
2Biological Therapy
11/2023 - 02/2015
1Secondary Prevention
01/2020
1Highly Active Antiretroviral Therapy (HAART)
02/2015